Skip to main content
. 2022 Jan 25;16:183–190. doi: 10.2147/OPTH.S350850

Table 2.

Summary of IOLSAT Questionnaire Results (n = 33)

Percentage of Subjects Rarely or Never Needing Glasses Percentage Reporting “Good” or “Very Good” Vision without Glasses
Condition Current Vivity SSE* Current Vivity SSE*
Overall 70 45.1
Bright Light Distance (“far away”) 85 94.1 85 93.7
Intermediate (“arm’s length”) 85 87.2 94 91.6
Near (“up close”) 73 46.1 70 57.3
Dim Light Distance (“far away”) 85 93.2 79 87.5
Intermediate (“arm’s length”) 88 84.3 76 83.4
Near (“up close”) 58 39.2 52 37.5

Notes: *PMA P930014/S126: FDA Summary of Safety and Effectiveness Data from US FDA. AcrySof™ IQ Vivity™ extended vision Intraocular Lens (IOL): Summary of safety and effectiveness data. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf/P930014S126B.pdf. Tables 32,33 6M.19